Immunity to Melanoma Antigens: From Self‐Tolerance to Immunotherapy
- 1 January 2006
- book chapter
- Published by Elsevier
- Vol. 90, 243-295
- https://doi.org/10.1016/s0065-2776(06)90007-8
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- A listing of human tumor antigens recognized by T cells: March 2004 updateCancer Immunology, Immunotherapy, 2004
- The strict regulation of lymphocyte migration to splenic white pulp does not involve common homing receptorsImmunology, 2002
- CD8+ T Cell Tolerance to a Tumor-associated Antigen Is Maintained at the Level of Expansion Rather than Effector FunctionThe Journal of Experimental Medicine, 2002
- Tyrosinase Degradation via Two Pathways during Reverse Translocation to the CytosolBiochemical and Biophysical Research Communications, 2001
- A Phase I Trial of an HLA-A1 Restricted MAGE-3 Epitope Peptide with Incomplete Freundʼs Adjuvant in Patients with Resected High-Risk MelanomaJournal of Immunotherapy, 1999
- Radiation-induced normal tissue injury: Role of adhesion molecules in leukocyte-endothelial cell interactionsInternational Journal of Cancer, 1999
- Murine Cutaneous Mastocytosis and Epidermal Melanocytosis Induced by Keratinocyte Expression of Transgenic Stem Cell FactorThe Journal of Experimental Medicine, 1998
- Molecular analysis of viable spontaneous and radiation-induced albino (c)-locus mutations in the mouseMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1993
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Vitiligo in patients with metastatic melanoma: A good prognostic signJournal of the American Academy of Dermatology, 1983